Bader Alahmari

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Hodgkin Lymphoma

Stem Cell Transplantation

Top Venues

Bone marrow transplantation

JCO global oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Adetola A Kassim, Josu de la Fuente, Erfan Nur, Karina Wilkerson, Ali D Alahmari, Adriana Seber, Carmem Maria Sales Bonfim, Belinda Pinto Simões, Mohsen Alzahrani, Michael J Eckrich, Biljana Horn, Rabi Hanna, Nathalie Dhedin, Hemalatha G Rangarajan, Roseane Vasconcelos Gouveia, Fahad Almohareb, Mahmoud Aljurf, Mohammed F Essa, Bader Alahmari, Katie S Gatwood, James A Connelly, Elisabeth Dovern, Mark Rodeghier, Michael Rutledge DeBaun
An International Learning Collaborative Phase 2 Trial for Haploidentical Bone Marrow Transplant in Sickle Cell Disease. Blood (2024)
Adetola A Kassim, Josu de la Fuente, Erfan Nur, Karina L Wilkerson, Ali D Alahmari, Adriana Seber, Carmem Maria Sales Bonfim, Belinda Pinto Simões, Mohsen Al Zahrani, Michael J Eckrich, Biljana Horn, Rabi Hanna, Nathalie Dhedin, Hemalatha G Rangarajan, Roseane Vasconcelos Gouveia, Fahad Almohareb, Mahmoud Aljurf, Mohammed F Essa, Bader Alahmari, Katie S Gatwood, James A Connelly, Elisabeth Dovern, Mark Rodeghier, Michael Rutledge DeBaun
An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease. Blood 143 (25) (2024)
Adetola A Kassim, Josu de la Fuente, Erfan Nur, Karina Wilkerson, Ali D Alahmari, Adriana Seber, Carmem Maria Sales Bonfim, Belinda Pinto Simões, Mohsen Alzahrani, Michael J Eckrich, Biljana Horn, Rabi Hanna, Nathalie Dhedin, Hemalatha G Rangarajan, Roseane Vasconcelos Gouveia, Fahad Almohareb, Mahmoud Aljurf, Mohammed F Essa, Bader Alahmari, Katie S Gatwood, James A Connelly, Elisabeth Dovern, Mark Rodeghier, Michael Rutledge DeBaun
An International Learning Collaborative Phase 2 Trial for Haploidentical Bone Marrow Transplant in Sickle Cell Disease. Blood (2024)
Moussab Damlaj, Mohamed Tlayjeh, Ahmad Damlaj, Bader Alahmari, Husam AlSadi, Mazin Ahmed, Zied AlJubour, Ayman Alhejazi, Hend Salama, Ayman Ibrahim, Abdulrahman Al Raizah, Mohammed Bakkar, Abdulraouf Ghori, Abdullah S Al Saleh, Ahmed S Al Askar, Mohsen Al Zahrani
Contemporary outcomes of high risk relapsed refractory classical hodgkin lymphoma patients-role of maintenance therapy in the real world. Bone marrow transplantation (2023)
Moussab Damlaj, Bader Alahmari, Ahmed S Al Askar, Ayman Alhejazi, Husam Alsadi, Inaam Shehab-Eddine, Abdulrahman Alghamdi, Walid Almashaqbeh, Heba Alshobaki, Isam Mahasneh, Ashwaq Alotaibi, Tahany Alanazi, Maybelle Balili, Mohammed Quarshi, Mazin Ahmed, Mohsen Al Zahrani
Feasibility of early sirolimus cessation post non-myeloablative transplantation in adult patients with severe sickle cell disease. Bone marrow transplantation 57 (2) (2022)
Abdullah S Al Saleh, Abdulrahman I Alghamdi, Mohsen Al Zahrani, Bader Alahmari, Ayman Alhejazi, Ahmed S Al Askar, Husam Alsadi, Suha Alkhraisat, Inaam Shehab-Eddine, Moussab Damlaj
Rates and predictors of infusion-related reactions in patients receiving standard versus prolonged infusion of rabbit anti-thymocyte globulin for hematopoietic stem cell transplantation, a retrospective analysis. Bone marrow transplantation 57 (7) (2022)
Khadega A Abuelgasim, Moussab Damlaj, Mohammad Bosaeed, Sumayyah Altamimi, Hind Abdullah, Reem M Ramli, Rahma Alzahrani, Nourah Alzughaibi, Bader Alahmari, Ayman Alhejazi, Ahmed S Al Askar, Mohsen Al Zahrani
Infectious complications in adult sickle cell anemia patients undergoing hematopoietic stem cell transplantation. Bone marrow transplantation 56 (12) (2021)
Mohsen Al Zahrani, Moussab Damlaj, Mohammed F Essa, Bader Alahmari, Ahmed S Al Askar, Ayman Hejazi, Enas Basher, Husam Alsadi, Mazin Ahmed, Rodaina Abujoub, Samer Ghazi, Heba Alshobaki, Khadega A Abuelgasim, Hind Salama, Giamal Gmati, Abdulrahman Alsultan
HLA-identical related hematopoietic stem cell transplantation in severe sickle cell disease: age is not a barrier to successful outcome. Bone marrow transplantation (2021)
Riad El Fakih, Alfadil Haroon, Feras Alfraih, Murtadha K Al-Khabori, Mohsen Al Zahrani, Ahmad Alhuraiji, Abdulaziz Hamadah, Naif I AlJohani, Bader Alahmari, Mohammed F Essa, Ibraheem H Motabi, Imran K Tailor, Reem S Almaghrabi, Khalil Al-Farsi, Ibraheem Abosoudah, Mouhab F Ayas, Tusneem A Elhassan, Ashraf M Suhebeh, Syed Osman Ahmed, Saud Alhayli, Panayotis Kaloyannidis, Ahmad Alsaeed, Khalid Al Anezi, Sameer Alamoudi, Moussab Damlaj, Hani Al Hashmi, Mahmoud Aljurf
Clinical course and outcomes of COVID-19 in hematopoietic cell transplant patients, a regional report from the Middle East. Bone marrow transplantation 56 (9) (2021)
Bader Alahmari, Mohsen Alzahrani, Nawal Al Shehry, Osamah Tawfiq, Turki Alwasaidi, Ayman Alhejazi, Mohammed Bakkar, Amal Al Behainy, Mansour Radwi, Ahmed S Al Askar
Management Approach to Acute Myeloid Leukemia Leveraging the Available Resources in View of the Latest Evidence: Consensus of the Saudi Society of Blood and Marrow Transplantation. JCO global oncology 7 (2021)
Bader Alahmari, Matthew L Cooper, Kiran Vij, Julie Ritchey, Peter Ruminski, Feng Gao, Jaebok Choi, John F DiPersio
Selective targeting of α4β1 integrin attenuates murine graft versus host disease. Leukemia 34 (11) (2020)
Moussab Damlaj, Khadega A Abuelgasim, Ayman Alhejazi, Bader Alahmari, Ahmed S Al Askar, Mohsen Alzahrani
Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma. Bone marrow transplantation 55 (12) (2020)
Khadega A Abuelgasim, Mohsen Alzahrani, Yousef Alsharhan, Moataz Khairi, Mohammed Hommady, Giamal Gmati, Hind Salama, Osama Ali, Bader Alahmari, Emad M Masuadi, Ahmed S Al Askar, Ayman Alhejazi, Moussab Damlaj
Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma. Bone marrow transplantation 54 (7) (2019)
Jaebok Choi, Matthew L Cooper, Karl Staser, Kidist Ashami, Kiran R Vij, Bing Wang, Lynne Marsala, Jessica Niswonger, Julie Ritchey, Bader Alahmari, Samuel Achilefu, Ikuo Tsunoda, Mark A Schroeder, John F DiPersio
Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease. Leukemia 32 (11) (2018)
Bader Alahmari, Matthew Cooper, Edward Ziga, Julie Ritchey, John F DiPersio, Jaebok Choi
Selective targeting of histone modification fails to prevent graft versus host disease after hematopoietic cell transplantation. PloS one 13 (11) (2018)